Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Medtronic has become aware of complaints related to third-party (non-medtronic) navigated instruments used in conjunction with medtronic navlock tracker instrumentation. the navlock trackers are performing as designed. third-party navigation instruments are being used without collaboration or agreement from medtronic the firms designing and marketing these devices may or may not have obtained the required clearance. medtronic has not validated any third party instrument for use with navlock trackers. instruments manufactured by a non-medtronic manufacturer have not been evaluated by medtronic for compatibility with the navlock.
“If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.